Lastest News
Alzheimer’s disease (AD) is a major global health issue, with over 55 million people affected worldwide. Early detection of AD is challenging, as there …
September 20, 2024
Profound Research (Profound), a leading clinical site network, and Cardiology and Vascular Associates (CAVA), a prominent cardiology and vascular medicine group, have announced a …
August 6, 2024
Profound Research, a leading clinical trial site network, today announced the key leadership appointment of Michael Shipton as Chief Commercial Officer, a move aimed …
August 6, 2024
Celebrating a Milestone in Alzheimer's Treatment Profound Research extends our heartfelt congratulations to our sponsor partner, Eli Lilly, on the recent approval of Kinsunla™ …
July 3, 2024
At Profound Research, we are dedicated to delivering clinical trials and advanced therapies to diverse communities across the nation. Today, we are thrilled to …
June 28, 2024
At Profound Research, we're committed to highlighting the individuals who are advancing medical science and patient care through their work in clinical research. Today, …
April 18, 2024
Skin Biopsy as a Potential Diagnostic Tool for Synucleinopathies Exploring Promising Avenues in Neurological Research The groundwork for a notable advancement in establishing new diagnostic …
April 17, 2024
At Profound Research, we're committed to highlighting the individuals who are advancing medical science and patient care through their work in clinical research. Today, …
April 3, 2024
At Profound Research, we strive to highlight the remarkable individuals who contribute to the advancement of medical science and patient care through clinical research. …
March 7, 2024
Nashville, TN - [February 8, 2024] - Profound Research, a leading clinical trial site network, today announced key leadership appointments aimed at driving innovation …
February 8, 2024
